Edmond de Rothschild’s portfolio company Vessix acquired by Boston Scientific
Edmond de Rothschild Investment Partners’ portfolio company Vessix Vascular has been acquired by Boston Scientific in a deal worth up to USD425m. Of this, USD125m will be paid at the closing with the balance upon achievement of certain clinical and sales milestones. Vessix has developed a catheter-based renal denervation system



